The Experts below are selected from a list of 4590 Experts worldwide ranked by ideXlab platform
J.j.m.c.h. De La Rosette - One of the best experts on this subject based on the ideXlab platform.
-
long term followup of randomized transurethral microwave Thermotherapy versus transurethral prostatic resection study
The Journal of Urology, 2001Co-Authors: D L Floratos, F M J Debruyne, Lambertus A Kiemeney, Cristina Rossi, Barbara B M Kortmann, J.j.m.c.h. De La RosetteAbstract:Purpose: We evaluate the durable effect of high-energy transurethral microwave Thermotherapy and transurethral prostatic resection for treatment of patients with lower urinary tract symptoms suggestive of bladder outflow obstruction.Materials and Methods: Between January 1996 and March 1997, 155 patients with lower urinary tract symptoms suggestive of bladder outflow obstruction were randomized to receive transurethral microwave Thermotherapy (Prostatron * *EDAP Technomed, Lyon, France.; device and commercial software) (82) or undergo transurethral prostatic resection (73). Initial patient evaluation was performed according to international standards. Patients were followed annually with the International Prostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kaplan-Meier survival analysis was used to calculate the cumulative risk of re-treatment, adjusted for loss to followup.Results: A total of 78 patients received transurethral microwave Thermotherapy and 66 underwent transurethral pr...
-
Long-term followup of randomized transurethral microwave Thermotherapy versus transurethral prostatic resection study.
'Elsevier BV', 2001Co-Authors: Floratus D., Rossi C., Kiemeney L.a.l.m., Kortmann B.b.m., Debruyne F.m.j., J.j.m.c.h. De La RosetteAbstract:Item does not contain fulltextPURPOSE: We evaluate the durable effect of high-energy transurethral microwave Thermotherapy and transurethral prostatic resection for treatment of patients with lower urinary tract symptoms suggestive of bladder outflow obstruction. MATERIALS AND METHODS: Between January 1996 and March 1997, 155 patients with lower urinary tract symptoms suggestive of bladder outflow obstruction were randomized to receive transurethral microwave Thermotherapy (Prostatron*; device and commercial software) (82) or undergo transurethral prostatic resection (73). Initial patient evaluation was performed according to international standards. Patients were followed annually with the International Prostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kaplan-Meier survival analysis was used to calculate the cumulative risk of re-treatment, adjusted for loss to followup. RESULTS: A total of 78 patients received transurethral microwave Thermotherapy and 66 underwent transurethral prostatic resection. Median followup was 33 months. In the Thermotherapy group mean maximum urinary flow rate improved from 9.2 ml. per second at baseline to 15.1, 14.5 and 11.9 ml. per second at 1, 2 and 3 years, and mean I-PSS decreased from 20 to 8, 9, and 12, respectively. In the resection group the corresponding numbers for maximum urinary flow rate were 7.8, 24.5, 23.0 and 24.7 ml. per second at 1, 2 and 3 years, and for I-PSS were 20, 3, 4 and 3, respectively. At 36 months, 14 patients in the Thermotherapy and 8 from the resection groups underwent re-treatment, and the cumulative risk was 19.8% (95% confidence interval 10.4% to 29.3%) and 12.9% (4.5% to 21.3%), respectively (p = 0.28). CONCLUSIONS: Transurethral microwave Thermotherapy and transurethral prostatic resection achieve durable improvement in patients with lower urinary tract symptoms suggestive of bladder outflow obstruction, while the magnitude of improvement is higher with resection. The repeat Thermotherapy is based on failure of therapy whereas repeat resection is based on complications of therapy
-
Long-term followup of randomized transurethral microwave Thermotherapy versus transurethral prostatic resection study.
'Elsevier BV', 2001Co-Authors: Floratus D., Rossi C., Kiemeney L.a.l.m., Kortmann B.b.m., Debruyne F.m.j., J.j.m.c.h. De La RosetteAbstract:PURPOSE: We evaluate the durable effect of high-energy transurethral microwave Thermotherapy and transurethral prostatic resection for treatment of patients with lower urinary tract symptoms suggestive of bladder outflow obstruction. MATERIALS AND METHODS: Between January 1996 and March 1997, 155 patients with lower urinary tract symptoms suggestive of bladder outflow obstruction were randomized to receive transurethral microwave Thermotherapy (Prostatron*; device and commercial software) (82) or undergo transurethral prostatic resection (73). Initial patient evaluation was performed according to international standards. Patients were followed annually with the International Prostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kaplan-Meier survival analysis was used to calculate the cumulative risk of re-treatment, adjusted for loss to followup. RESULTS: A total of 78 patients received transurethral microwave Thermotherapy and 66 underwent transurethral prostatic resection. Median followup was 33 months. In the Thermotherapy group mean maximum urinary flow rate improved from 9.2 ml. per second at baseline to 15.1, 14.5 and 11.9 ml. per second at 1, 2 and 3 years, and mean I-PSS decreased from 20 to 8, 9, and 12, respectively. In the resection group the corresponding numbers for maximum urinary flow rate were 7.8, 24.5, 23.0 and 24.7 ml. per second at 1, 2 and 3 years, and for I-PSS were 20, 3, 4 and 3, respectively. At 36 months, 14 patients in the Thermotherapy and 8 from the resection groups underwent re-treatment, and the cumulative risk was 19.8% (95% confidence interval 10.4% to 29.3%) and 12.9% (4.5% to 21.3%), respectively (p = 0.28). CONCLUSIONS: Transurethral microwave Thermotherapy and transurethral prostatic resection achieve durable improvement in patients with lower urinary tract symptoms suggestive of bladder outflow obstruction, while the magnitude of improvement is higher with resection. The repeat Thermotherapy is based on failure of therapy whereas repeat resection is based on complications of therapy
-
sexual function following high energy microwave Thermotherapy results of a randomized controlled study comparing transurethral microwave Thermotherapy to transurethral prostatic resection
The Journal of Urology, 1999Co-Authors: E A E Francisca, F C H Dancona, E J H Meuleman, F M J Debruyne, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluate changes in sexual function in patients treated with high energy transurethral microwave Thermotherapy compared to transurethral resection of the prostate.Materials and Methods: A total of 147 patients randomized to undergo transurethral microwave Thermotherapy or transurethral resection of the prostate were asked to complete a self-administered questionnaire evaluating sexual function before, and 3 and 12 months after treatment. The questionnaire dealt with such items as social status, libido, quality of erection, ejaculation and overall satisfaction of sexual functioning.Results: There was a statistically significant improvement of micturition in both groups. The improvement in the transurethral prostatic resection group was significantly better than in the transurethral microwave Thermotherapy group. Antegrade ejaculation occurred at 3 months following treatment in 27% of the transurethral prostatic resection group compared to 74% of the transurethral microwave Thermotherapy...
-
quality of life assessment in patients treated with lower energy Thermotherapy prostasoft 2 0 results of a randomized transurethral microwave Thermotherapy versus sham study
The Journal of Urology, 1997Co-Authors: E A E Francisca, F C H Dancona, F M J Debruyne, Lambertus A Kiemeney, J C M Hendriks, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluated the impact of lower energy transurethral microwave Thermotherapy on quality of life and quality of sexual function in patients with benign prostatic hyperplasia (BPH).Materials and Methods: A total of 50 patients with BPH were randomized to receive either lower energy transurethral microwave Thermotherapy treatment (Prostasoft 2.0) * *Technomed Medical Systems, Lyon, France. or placebo treatment and followed for 26 weeks after treatment. All patients completed a Madsen symptom score and quality of life questionnaire to assess acceptability, daily activities, psychological well-being, social activities and improvement in quality of life. A sexual function questionnaire was used to assess changes in sexual function after microwave Thermotherapy.Results: A significant difference in voiding parameters and symptom score was found between the transurethral microwave Thermotherapy and sham groups. Maximum uroflow changed from 9.6 ml. per second at baseline to 13.9 ml. per second and...
F M J Debruyne - One of the best experts on this subject based on the ideXlab platform.
-
long term followup of randomized transurethral microwave Thermotherapy versus transurethral prostatic resection study
The Journal of Urology, 2001Co-Authors: D L Floratos, F M J Debruyne, Lambertus A Kiemeney, Cristina Rossi, Barbara B M Kortmann, J.j.m.c.h. De La RosetteAbstract:Purpose: We evaluate the durable effect of high-energy transurethral microwave Thermotherapy and transurethral prostatic resection for treatment of patients with lower urinary tract symptoms suggestive of bladder outflow obstruction.Materials and Methods: Between January 1996 and March 1997, 155 patients with lower urinary tract symptoms suggestive of bladder outflow obstruction were randomized to receive transurethral microwave Thermotherapy (Prostatron * *EDAP Technomed, Lyon, France.; device and commercial software) (82) or undergo transurethral prostatic resection (73). Initial patient evaluation was performed according to international standards. Patients were followed annually with the International Prostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kaplan-Meier survival analysis was used to calculate the cumulative risk of re-treatment, adjusted for loss to followup.Results: A total of 78 patients received transurethral microwave Thermotherapy and 66 underwent transurethral pr...
-
sexual function following high energy microwave Thermotherapy results of a randomized controlled study comparing transurethral microwave Thermotherapy to transurethral prostatic resection
The Journal of Urology, 1999Co-Authors: E A E Francisca, F C H Dancona, E J H Meuleman, F M J Debruyne, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluate changes in sexual function in patients treated with high energy transurethral microwave Thermotherapy compared to transurethral resection of the prostate.Materials and Methods: A total of 147 patients randomized to undergo transurethral microwave Thermotherapy or transurethral resection of the prostate were asked to complete a self-administered questionnaire evaluating sexual function before, and 3 and 12 months after treatment. The questionnaire dealt with such items as social status, libido, quality of erection, ejaculation and overall satisfaction of sexual functioning.Results: There was a statistically significant improvement of micturition in both groups. The improvement in the transurethral prostatic resection group was significantly better than in the transurethral microwave Thermotherapy group. Antegrade ejaculation occurred at 3 months following treatment in 27% of the transurethral prostatic resection group compared to 74% of the transurethral microwave Thermotherapy...
-
quality of life assessment in patients treated with lower energy Thermotherapy prostasoft 2 0 results of a randomized transurethral microwave Thermotherapy versus sham study
The Journal of Urology, 1997Co-Authors: E A E Francisca, F C H Dancona, F M J Debruyne, Lambertus A Kiemeney, J C M Hendriks, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluated the impact of lower energy transurethral microwave Thermotherapy on quality of life and quality of sexual function in patients with benign prostatic hyperplasia (BPH).Materials and Methods: A total of 50 patients with BPH were randomized to receive either lower energy transurethral microwave Thermotherapy treatment (Prostasoft 2.0) * *Technomed Medical Systems, Lyon, France. or placebo treatment and followed for 26 weeks after treatment. All patients completed a Madsen symptom score and quality of life questionnaire to assess acceptability, daily activities, psychological well-being, social activities and improvement in quality of life. A sexual function questionnaire was used to assess changes in sexual function after microwave Thermotherapy.Results: A significant difference in voiding parameters and symptom score was found between the transurethral microwave Thermotherapy and sham groups. Maximum uroflow changed from 9.6 ml. per second at baseline to 13.9 ml. per second and...
-
three year followup of patients treated with lower energy microwave Thermotherapy
The Journal of Urology, 1996Co-Authors: M J A M De Wildt, S. St. C. Carter, F C H Dancona, F M J Debruyne, M R Hubregtse, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: A retrospective study was done to investigate the long-term outcome of patients treated with lower energy transurethral microwave Thermotherapy.Materials and Methods: A total of 305 patients with lower urinary tract symptoms and benign prostatic hypertrophy underwent transurethral microwave Thermotherapy according to a similar protocol at 2 centers.Results: After 3 years of followup 133 patients who had undergone transurethral microwave Thermotherapy alone were available for study. During this observation period significant symptomatic improvement from baseline and an improved maximum flow rate of 2.6 ml. per second were noted. Of the patients 125 underwent invasive or medical treatment.Conclusions: After 3 years of followup lower energy transurethral microwave Thermotherapy showed significant and durable improvements in baseline parameters in 52 percent of the patients.
De La Rosette, J. J. - One of the best experts on this subject based on the ideXlab platform.
-
Long-term followup of randomized transurethral microwave Thermotherapy versus transurethral prostatic resection study
2001Co-Authors: Floratos D. L., Kiemeney L. A., Debruyne F. M., Rossi C., Kortmann B. B., De La Rosette, J. J.Abstract:We evaluate the durable effect of high-energy transurethral microwave Thermotherapy and transurethral prostatic resection for treatment of patients with lower urinary tract symptoms suggestive of bladder outflow obstruction. Between January 1996 and March 1997, 155 patients with lower urinary tract symptoms suggestive of bladder outflow obstruction were randomized to receive transurethral microwave Thermotherapy (Prostatron*; device and commercial software) (82) or undergo transurethral prostatic resection (73). Initial patient evaluation was performed according to international standards. Patients were followed annually with the International Prostate Symptom Score (I-PSS) and uroflowmetry (maximum flow rate). The Kaplan-Meier survival analysis was used to calculate the cumulative risk of re-treatment, adjusted for loss to followup. A total of 78 patients received transurethral microwave Thermotherapy and 66 underwent transurethral prostatic resection. Median followup was 33 months. In the Thermotherapy group mean maximum urinary flow rate improved from 9.2 ml. per second at baseline to 15.1, 14.5 and 11.9 ml. per second at 1, 2 and 3 years, and mean I-PSS decreased from 20 to 8, 9, and 12, respectively. In the resection group the corresponding numbers for maximum urinary flow rate were 7.8, 24.5, 23.0 and 24.7 ml. per second at 1, 2 and 3 years, and for I-PSS were 20, 3, 4 and 3, respectively. At 36 months, 14 patients in the Thermotherapy and 8 from the resection groups underwent re-treatment, and the cumulative risk was 19.8% (95% confidence interval 10.4% to 29.3%) and 12.9% (4.5% to 21.3%), respectively (p = 0.28). Transurethral microwave Thermotherapy and transurethral prostatic resection achieve durable improvement in patients with lower urinary tract symptoms suggestive of bladder outflow obstruction, while the magnitude of improvement is higher with resection. The repeat Thermotherapy is based on failure of therapy whereas repeat resection is based on complications of therap
-
Sexual function following high energy microwave Thermotherapy: results of a randomized controlled study comparing transurethral microwave Thermotherapy to transurethral prostatic resection
1999Co-Authors: Francisca E. A., D'ancona F. C., Debruyne F. M., Meuleman E. J., De La Rosette, J. J.Abstract:We evaluate changes in sexual function in patients treated with high energy transurethral microwave Thermotherapy compared to transurethral resection of the prostate. A total of 147 patients randomized to undergo transurethral microwave Thermotherapy or transurethral resection of the prostate were asked to complete a self-administered questionnaire evaluating sexual function before, and 3 and 12 months after treatment. The questionnaire dealt with such items as social status, libido, quality of erection, ejaculation and overall satisfaction of sexual functioning. There was a statistically significant improvement of micturition in both groups. The improvement in the transurethral prostatic resection group was significantly better than in the transurethral microwave Thermotherapy group. Antegrade ejaculation occurred at 3 months following treatment in 27% of the transurethral prostatic resection group compared to 74% of the transurethral microwave Thermotherapy group and at 1 year in 37 and 67%, respectively. Significantly more patients undergoing transurethral prostatic resection (36%) had changes in sexual function compared to the transurethral microwave Thermotherapy group (17%). The transurethral microwave Thermotherapy group was more satisfied with the sex life. Of these patients 55% graded sex as very satisfying compared to 21% in the transurethral prostatic resection group. The severity of symptoms was not correlated with sexual function in this study. In general, older patients had sexual dysfunction more often, while younger patients had pain during sexual activities more frequently. Although clinically less effective, high energy transurethral microwave Thermotherapy is a better therapeutic option than surgery for patients who want to preserve sexual function. In particular ejaculation is often preserved after transurethral microwave Thermotherapy while there is significant deterioration following transurethral prostatic resection. In general, older patients have greater sexual dysfunctio
-
Long-term results of lower energy transurethral microwave Thermotherapy
1998Co-Authors: Keijzers G. B., Francisca E. A., D'ancona F. C., Kiemeney L. A., Debruyne F. M., De La Rosette, J. J.Abstract:We evaluate long-term results of lower energy transurethral microwave Thermotherapy (Prostasoft 2.0*) and identify pretreatment characteristics that predict a favorable outcome. Between December 1990 and December 1992, 231 patients with lower urinary tract symptoms were treated with lower energy transurethral microwave Thermotherapy. Subjective and objective voiding parameters were collected from medical records and a self-administered questionnaire. Kaplan-Meier plots were constructed to assess the risk of re-treatment. Of the patients 41% underwent invasive re-treatment within 5 years of followup and 17% were re-treated with medication. The re-treatment-free period was somewhat longer in patients with a peak flow rate greater than 10 ml. per second, a Madsen score 15 or less, a post-void residual volume 100 ml. or less and age greater than 65 years at baseline. Prostate volume did not modify the outcome. No incontinence was caused by transurethral microwave Thermotherapy, 8% had recurrent urinary tract infection and 8% had retrograde ejaculation. Only 1 patient had a urethral stricture after transurethral microwave Thermotherapy. At 5 years after transurethral microwave Thermotherapy 41% of the patients received instrumental treatment. Patients with a lower Madsen score and lower residual volume, and those with higher peak flow and age were somewhat better responders to lower energy transurethral microwave thermotherap
-
Quality of life assessment in patients treated with lower energy Thermotherapy (Prostasoft 2.0): results of a randomized transurethral microwave Thermotherapy versus sham study
1997Co-Authors: Francisca E. A., D'ancona F. C., Kiemeney L. A., Debruyne F. M., Hendriks J. C., De La Rosette, J. J.Abstract:We evaluated the impact of lower energy transurethral microwave Thermotherapy on quality of life and quality of sexual function in patients with benign prostatic hyperplasia (BPH). A total of 50 patients with BPH were randomized to receive either lower energy transurethral microwave Thermotherapy treatment (Prostasoft 2.0) or placebo treatment and followed for 26 weeks after treatment. All patients completed a Madsen symptom score and quality of life questionnaire to assess acceptability, daily activities, psychological well-being, social activities and improvement in quality of life. A sexual function questionnaire was used to assess changes in sexual function after microwave Thermotherapy. A significant difference in voiding parameters and symptom score was found between the transurethral microwave Thermotherapy and sham groups. Maximum uroflow changed from 9.6 ml. per second at baseline to 13.9 ml. per second and from 9.9 ml. per second at baseline to 9.6 ml. per second at 26 weeks for transurethral microwave Thermotherapy and sham groups, respectively. Madsen score improved from 13.2 to 5.3 for the transurethral microwave Thermotherapy group and from 11.9 to 9.1 for the sham group. For quality of life measures, a statistically significant difference in favor of the transurethral microwave Thermotherapy group was found only for the acceptability item. At baseline and after 26 weeks no statistically significant difference was observed between the 2 groups for Quality of Life measures documenting sexual function. However, almost 20% of patients treated by either transurethral microwave Thermotherapy or sham claimed at 26 weeks after treatment that treatment had influenced sexual function. Although significant changes in objective and subjective parameters were found in patients after lower energy microwave Thermotherapy, the change in quality of life was minimal. In addition to the minimal invasiveness of transurethral microwave Thermotherapy, preservation of sexual function is appealin
-
Current status of Thermotherapy of the prostate
1997Co-Authors: De La Rosette, J. J., D'ancona F. C., Debruyne F. M.Abstract:We reviewed the available data on transurethral microwave Thermotherapy in the treatment of patients with benign prostatic hyperplasia (BPH). Furthermore we provide a perspective of this minimally invasive treatment modality. To our knowledge all previously reported data from clinical trials of transurethral microwave Thermotherapy for BPH are reviewed. Transurethral microwave Thermotherapy was designed to apply microwave energy deep within lateral prostatic lobes while simultaneously cooling the urethral mucosa, thus enabling an outpatient based anesthesia-free procedure. Lower energy protocols using the Prostraton device provide significant symptomatic improvement and improvement in maximum flow of approximately 35% over baseline. Similar changes are being documented with other transurethral microwave Thermotherapy devices. Higher energy protocols using the Prostatron device result in symptomatic improvement similar to that of lower energy protocols, while improvement in uroflowmetry is much more pronounced. However, the latter effect is achieved at the expense of increased morbidity. Second generation protocols have not yet been documented by users of the other Thermotherapy devices. Numerous studies unequivocally support the efficacy and safety of transurethral microwave Thermotherapy for treatment of symptomatic BPH. Significant improvement in objective and subjective parameters has been realized with transurethral microwave Thermotherapy at multiple centers in the United States and Europ
F C H Dancona - One of the best experts on this subject based on the ideXlab platform.
-
sexual function following high energy microwave Thermotherapy results of a randomized controlled study comparing transurethral microwave Thermotherapy to transurethral prostatic resection
The Journal of Urology, 1999Co-Authors: E A E Francisca, F C H Dancona, E J H Meuleman, F M J Debruyne, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluate changes in sexual function in patients treated with high energy transurethral microwave Thermotherapy compared to transurethral resection of the prostate.Materials and Methods: A total of 147 patients randomized to undergo transurethral microwave Thermotherapy or transurethral resection of the prostate were asked to complete a self-administered questionnaire evaluating sexual function before, and 3 and 12 months after treatment. The questionnaire dealt with such items as social status, libido, quality of erection, ejaculation and overall satisfaction of sexual functioning.Results: There was a statistically significant improvement of micturition in both groups. The improvement in the transurethral prostatic resection group was significantly better than in the transurethral microwave Thermotherapy group. Antegrade ejaculation occurred at 3 months following treatment in 27% of the transurethral prostatic resection group compared to 74% of the transurethral microwave Thermotherapy...
-
quality of life assessment in patients treated with lower energy Thermotherapy prostasoft 2 0 results of a randomized transurethral microwave Thermotherapy versus sham study
The Journal of Urology, 1997Co-Authors: E A E Francisca, F C H Dancona, F M J Debruyne, Lambertus A Kiemeney, J C M Hendriks, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluated the impact of lower energy transurethral microwave Thermotherapy on quality of life and quality of sexual function in patients with benign prostatic hyperplasia (BPH).Materials and Methods: A total of 50 patients with BPH were randomized to receive either lower energy transurethral microwave Thermotherapy treatment (Prostasoft 2.0) * *Technomed Medical Systems, Lyon, France. or placebo treatment and followed for 26 weeks after treatment. All patients completed a Madsen symptom score and quality of life questionnaire to assess acceptability, daily activities, psychological well-being, social activities and improvement in quality of life. A sexual function questionnaire was used to assess changes in sexual function after microwave Thermotherapy.Results: A significant difference in voiding parameters and symptom score was found between the transurethral microwave Thermotherapy and sham groups. Maximum uroflow changed from 9.6 ml. per second at baseline to 13.9 ml. per second and...
-
three year followup of patients treated with lower energy microwave Thermotherapy
The Journal of Urology, 1996Co-Authors: M J A M De Wildt, S. St. C. Carter, F C H Dancona, F M J Debruyne, M R Hubregtse, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: A retrospective study was done to investigate the long-term outcome of patients treated with lower energy transurethral microwave Thermotherapy.Materials and Methods: A total of 305 patients with lower urinary tract symptoms and benign prostatic hypertrophy underwent transurethral microwave Thermotherapy according to a similar protocol at 2 centers.Results: After 3 years of followup 133 patients who had undergone transurethral microwave Thermotherapy alone were available for study. During this observation period significant symptomatic improvement from baseline and an improved maximum flow rate of 2.6 ml. per second were noted. Of the patients 125 underwent invasive or medical treatment.Conclusions: After 3 years of followup lower energy transurethral microwave Thermotherapy showed significant and durable improvements in baseline parameters in 52 percent of the patients.
E A E Francisca - One of the best experts on this subject based on the ideXlab platform.
-
sexual function following high energy microwave Thermotherapy results of a randomized controlled study comparing transurethral microwave Thermotherapy to transurethral prostatic resection
The Journal of Urology, 1999Co-Authors: E A E Francisca, F C H Dancona, E J H Meuleman, F M J Debruyne, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluate changes in sexual function in patients treated with high energy transurethral microwave Thermotherapy compared to transurethral resection of the prostate.Materials and Methods: A total of 147 patients randomized to undergo transurethral microwave Thermotherapy or transurethral resection of the prostate were asked to complete a self-administered questionnaire evaluating sexual function before, and 3 and 12 months after treatment. The questionnaire dealt with such items as social status, libido, quality of erection, ejaculation and overall satisfaction of sexual functioning.Results: There was a statistically significant improvement of micturition in both groups. The improvement in the transurethral prostatic resection group was significantly better than in the transurethral microwave Thermotherapy group. Antegrade ejaculation occurred at 3 months following treatment in 27% of the transurethral prostatic resection group compared to 74% of the transurethral microwave Thermotherapy...
-
quality of life assessment in patients treated with lower energy Thermotherapy prostasoft 2 0 results of a randomized transurethral microwave Thermotherapy versus sham study
The Journal of Urology, 1997Co-Authors: E A E Francisca, F C H Dancona, F M J Debruyne, Lambertus A Kiemeney, J C M Hendriks, J.j.m.c.h. De La RosetteAbstract:AbstractPurpose: We evaluated the impact of lower energy transurethral microwave Thermotherapy on quality of life and quality of sexual function in patients with benign prostatic hyperplasia (BPH).Materials and Methods: A total of 50 patients with BPH were randomized to receive either lower energy transurethral microwave Thermotherapy treatment (Prostasoft 2.0) * *Technomed Medical Systems, Lyon, France. or placebo treatment and followed for 26 weeks after treatment. All patients completed a Madsen symptom score and quality of life questionnaire to assess acceptability, daily activities, psychological well-being, social activities and improvement in quality of life. A sexual function questionnaire was used to assess changes in sexual function after microwave Thermotherapy.Results: A significant difference in voiding parameters and symptom score was found between the transurethral microwave Thermotherapy and sham groups. Maximum uroflow changed from 9.6 ml. per second at baseline to 13.9 ml. per second and...
